Cancer cells cooperate to fight off the immune system and overcome therapy
New research from the lab of Thomas Gajewski, MD, PhD, showed that tumor cells can escape T cell killing during immunotherapy by using “clonal cooperation.” This work suggests that early treatment with immunotherapies may be more effective, before tumor cell heterogeneity emerges.
Diffuse large B-cell lymphoma: What you need to know about diagnosis and treatments
Sonali Smith, MD, an expert on lymphoma, answers questions about non-Hodgkin lymphoma and discusses exciting new advances in the treatment for relapsed disease.
Three years after CAR T-cell therapy for lymphoma, patient still cancer-free
Scott McIntyre, the first CAR T-cell therapy patient to be treated in Illinois, reflects on the past four years, grateful to have his normal life back.
